ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Selenocysteine is unique among amino acids in that it doesn’t have its own transfer RNA synthetase enzyme but is instead synthesized directly on its specific tRNA (tRNASec). An enzyme known as SepSecS catalyzes the still poorly understood final step in this process in which a phosphoseryl group is converted to selenocysteinyl using selenophosphate as the selenium donor. Dieter Söll of Yale University; Miljan Simonovi´c of the University of Illinois, Chicago; and coworkers now report a 2.8-Å resolution X-ray crystal structure of human tRNASec complexed with SepSecS, phosphoserine, and thiophosphate that provides a better view on how selenocysteine biosynthesis plays out (Science 2009, 325, 321). With the crystal structure and other data in hand, the researchers propose that the phosphoseryl-to-selenocysteinyl conversion occurs via a pyridoxal phosphate (PLP)-dependent mechanism involving a dehydroalanine intermediate. The lack of an aspartate anion to stabilize the protonated nitrogen atom of PLP’s pyridine ring distinguishes SepSecS from most other PLP enzymes, they note. A subsequent series of reactions involving phosphate and selenophosphate completes the pathway from the intermediate to selenocysteine.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X